Literature DB >> 19638401

Histone deacetylases facilitate sodium/calcium exchanger up-regulation in adult cardiomyocytes.

Sangeetha Chandrasekaran1, Richard E Peterson, Santhosh K Mani, Benjamin Addy, Avery L Buchholz, Lin Xu, Thirumagal Thiyagarajan, Harinath Kasiganesan, Christine B Kern, Donald R Menick.   

Abstract

It is becoming increasingly evident that histone deacetylases (HDACs) have a prominent role in the alteration of gene expression during the growth remodeling process of cardiac hypertrophy. HDACs are generally viewed as corepressors of gene expression. However, we demonstrate that class I and class II HDACs play an important role in the basal expression and up-regulation of the sodium calcium exchanger (Ncx1) gene in adult cardiomyocytes. Treatment with the HDAC inhibitor trichostatin A (TSA) prevented the pressure-overload-stimulated up-regulation of Ncx1 expression. Overexpression of HDAC5 resulted in the dose-dependent up-regulation of basal and alpha-adrenergic stimulated Ncx1 expression. We show that Nkx2.5 recruits HDAC5 to the Ncx1 promoter, where HDAC5 complexes with HDAC1. Nkx2.5 also interacts with transcriptional activator p300, which is recruited to the Ncx1 promoter. We demonstrate that when Nkx2.5 is acetylated, it is found associated with HDAC5, whereas deacetylated Nkx2.5 is in complex with p300. Notably, TSA treatment prevents p300 from being recruited to the endogenous Ncx1 promoter, resulting in the repression of Ncx1 expression. We propose a novel model for Ncx1 regulation in which deacetylation of Nkx2.5 is required for the recruitment of p300 and results in up-regulation of exchanger expression.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19638401      PMCID: PMC2775004          DOI: 10.1096/fj.09-132415

Source DB:  PubMed          Journal:  FASEB J        ISSN: 0892-6638            Impact factor:   5.191


  63 in total

Review 1.  Control of muscle development by dueling HATs and HDACs.

Authors:  T A McKinsey; C L Zhang; E N Olson
Journal:  Curr Opin Genet Dev       Date:  2001-10       Impact factor: 5.578

2.  Deacetylation of p53 modulates its effect on cell growth and apoptosis.

Authors:  J Luo; F Su; D Chen; A Shiloh; W Gu
Journal:  Nature       Date:  2000-11-16       Impact factor: 49.962

3.  Arrhythmogenesis and contractile dysfunction in heart failure: Roles of sodium-calcium exchange, inward rectifier potassium current, and residual beta-adrenergic responsiveness.

Authors:  S M Pogwizd; K Schlotthauer; L Li; W Yuan; D M Bers
Journal:  Circ Res       Date:  2001-06-08       Impact factor: 17.367

4.  Identification of a signal-responsive nuclear export sequence in class II histone deacetylases.

Authors:  T A McKinsey; C L Zhang; E N Olson
Journal:  Mol Cell Biol       Date:  2001-09       Impact factor: 4.272

5.  Activation of the myocyte enhancer factor-2 transcription factor by calcium/calmodulin-dependent protein kinase-stimulated binding of 14-3-3 to histone deacetylase 5.

Authors:  T A McKinsey; C L Zhang; E N Olson
Journal:  Proc Natl Acad Sci U S A       Date:  2000-12-19       Impact factor: 11.205

6.  Beta-adrenergic cardiac hypertrophy is mediated primarily by the beta(1)-subtype in the rat heart.

Authors:  C Morisco; D C Zebrowski; D E Vatner; S F Vatner; J Sadoshima
Journal:  J Mol Cell Cardiol       Date:  2001-03       Impact factor: 5.000

7.  Impaired contractile performance of cultured rabbit ventricular myocytes after adenoviral gene transfer of Na(+)-Ca(2+) exchanger.

Authors:  W Schillinger; P M Janssen; S Emami; S A Henderson; R S Ross; N Teucher; O Zeitz; K D Philipson; J Prestle; G Hasenfuss
Journal:  Circ Res       Date:  2000-09-29       Impact factor: 17.367

8.  In vivo regulation of Na/Ca exchanger expression by adrenergic effectors.

Authors:  K L Golden; J Ren; J O'Connor; A Dean; S E DiCarlo; J D Marsh
Journal:  Am J Physiol Heart Circ Physiol       Date:  2001-03       Impact factor: 4.733

Review 9.  Histone acetylation and the cell-cycle in cancer.

Authors:  C Wang; M Fu; S Mani; S Wadler; A M Senderowicz; R G Pestell
Journal:  Front Biosci       Date:  2001-04-01

10.  Inhibition of class I histone deacetylase with an apicidin derivative prevents cardiac hypertrophy and failure.

Authors:  Pasquale Gallo; Michael V G Latronico; Paolo Gallo; Serena Grimaldi; Francesco Borgia; Matilde Todaro; Philip Jones; Paola Gallinari; Raffaele De Francesco; Gennaro Ciliberto; Christian Steinkühler; Giovanni Esposito; Gianluigi Condorelli
Journal:  Cardiovasc Res       Date:  2008-08-12       Impact factor: 10.787

View more
  19 in total

1.  Acetylation: a lysine modification with neuroprotective effects in ischemic retinal degeneration.

Authors:  Oday Alsarraf; Jie Fan; Mohammad Dahrouj; C James Chou; Donald R Menick; Craig E Crosson
Journal:  Exp Eye Res       Date:  2014-07-23       Impact factor: 3.467

Review 2.  Elucidating the mechanisms of transcription regulation during heart development by next-generation sequencing.

Authors:  Keisuke Nimura; Yasufumi Kaneda
Journal:  J Hum Genet       Date:  2015-07-23       Impact factor: 3.172

Review 3.  Targeting transcriptional machinery to inhibit enhancer-driven gene expression in heart failure.

Authors:  Rachel A Minerath; Duane D Hall; Chad E Grueter
Journal:  Heart Fail Rev       Date:  2019-09       Impact factor: 4.214

4.  Inhibition of class I histone deacetylase activity represses matrix metalloproteinase-2 and -9 expression and preserves LV function postmyocardial infarction.

Authors:  Santhosh K Mani; Christine B Kern; Denise Kimbrough; Benjamin Addy; Harinath Kasiganesan; William T Rivers; Risha K Patel; James C Chou; Francis G Spinale; Rupak Mukherjee; Donald R Menick
Journal:  Am J Physiol Heart Circ Physiol       Date:  2015-03-20       Impact factor: 4.733

5.  Histone deacetylase 3 mediates allergic skin inflammation by regulating expression of MCP1 protein.

Authors:  Youngmi Kim; Kyungjong Kim; Deokbum Park; Eunmi Lee; Hansoo Lee; Yun-Sil Lee; Jongseon Choe; Dooil Jeoung
Journal:  J Biol Chem       Date:  2012-06-07       Impact factor: 5.157

Review 6.  Roles and targets of class I and IIa histone deacetylases in cardiac hypertrophy.

Authors:  Hae Jin Kee; Hyun Kook
Journal:  J Biomed Biotechnol       Date:  2010-11-29

7.  Synergistic induction of miR-126 by hypoxia and HDAC inhibitors in cardiac myocytes.

Authors:  Huaping Shi; Lei Chen; Huilan Wang; Shoukang Zhu; Chunming Dong; Keith A Webster; Jianqin Wei
Journal:  Biochem Biophys Res Commun       Date:  2012-11-29       Impact factor: 3.575

8.  Signal-dependent repression of DUSP5 by class I HDACs controls nuclear ERK activity and cardiomyocyte hypertrophy.

Authors:  Bradley S Ferguson; Brooke C Harrison; Mark Y Jeong; Brian G Reid; Michael F Wempe; Florence F Wagner; Edward B Holson; Timothy A McKinsey
Journal:  Proc Natl Acad Sci U S A       Date:  2013-05-29       Impact factor: 11.205

Review 9.  Epigenetic mechanisms in heart failure pathogenesis.

Authors:  Thomas G Di Salvo; Saptarsi M Haldar
Journal:  Circ Heart Fail       Date:  2014-09       Impact factor: 8.790

Review 10.  The role and molecular mechanism of epigenetics in cardiac hypertrophy.

Authors:  Hao Lei; Jiahui Hu; Kaijun Sun; Danyan Xu
Journal:  Heart Fail Rev       Date:  2021-11       Impact factor: 4.214

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.